Recent studies have demonstrated that TUBA1C is upregulated in different types of cancers, including bladder cancer, breast cancer, and pancreatic ductal adenocarcinoma, and this upregulation is correlated with increased tumor progression and metastasis (16, 35–37). This evidence concerns the gene TUBA1C and cancer.